These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Revisiting nuclear phospholipase C signalling in MDS. Follo MY; Faenza I; Fiume R; Ramazzotti G; McCubrey JA; Martelli AM; Manzoli FA; Cocco L Adv Biol Regul; 2012 Jan; 52(1):2-6. PubMed ID: 21982979 [No Abstract] [Full Text] [Related]
48. Phosphoinositide signalling in the nucleus. Keune Wj; Bultsma Y; Sommer L; Jones D; Divecha N Adv Enzyme Regul; 2011; 51(1):91-9. PubMed ID: 21035491 [No Abstract] [Full Text] [Related]
49. Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes. Cocco L; Faenza I; Follo MY; Ramazzotti G; Gaboardi GC; Billi AM; Martelli AM; Manzoli L Adv Enzyme Regul; 2008; 48():2-9. PubMed ID: 18280812 [No Abstract] [Full Text] [Related]
50. The physiology and pathology of inositide signaling in the nucleus. Ramazzotti G; Faenza I; Fiume R; Matteucci A; Piazzi M; Follo MY; Cocco L J Cell Physiol; 2011 Jan; 226(1):14-20. PubMed ID: 20658523 [TBL] [Abstract][Full Text] [Related]
51. Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology. Cocco L; Faenza I; Follo MY; Billi AM; Ramazzotti G; Papa V; Martelli AM; Manzoli L Adv Enzyme Regul; 2009; 49(1):2-10. PubMed ID: 19159640 [No Abstract] [Full Text] [Related]